Novavax Announces Approval of Nuvaxovid(TM) COVID-19 Vaccine for Primary and Booster Immunization in Japan
By asianet
— Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in Japan — Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced … Continued